Rituximab Treatment of Patients with Severe, Corticosteroid-Resistant Thyroid-Associated Ophthalmopathy

Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20

ME Reff, K Carner, KS Chambers et al. · Blood · 1994 · 1.9K citations · Full text

Life Sciences, Immunology, Pathology +14

Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach.

Maarten P. Mourits, Leo Koornneef, Wilmar M. Wiersinga et al. · British Journal of Ophthalmology · 1989 · 710 citations · Full text

Medicine, Ophthalmology, Surgery +13

Treatment of Graves’ disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study

Mario Salvi, Guia Vannucchi, Irene Campi et al. · European Journal of Endocrinology · 2007 · 262 citations

Medicine, Endocrinology, Ophthalmology +17

Comparison of the Effectiveness and Tolerability of Intravenous or Oral Glucocorticoids Associated with Orbital Radiotherapy in the Management of Severe Graves’ Ophthalmopathy: Results of a Prospective, Single-Blind, Randomized Study

Claudio Marcocci, Luigi Bartalena, Maria Laura Tanda et al. · The Journal of Clinical Endocrinology & Metabolism · 2001 · 256 citations

Pharmacy, Ophthalmology, Pharmacotherapy +13

Consensus statement on the use of rituximab in patients with rheumatoid arthritis

Josef S Smolen, Edward Keystone, Paul Emery et al. · Annals of the Rheumatic Diseases · 2006 · 226 citations · Full text

Medicine, Immunology, Oncology +16